Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02748577 · ClinicalTrials.gov registry record · NA

Pain Processing in Adults With Migraines

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
121
Enrollment target

NCT02748577 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 121 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02748577, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target

Study Summary

Primary Objective of this study: To assess experimental heat pain responses (pain intensity, pain unpleasantness, pain catastrophizing, emotional reactivity) in migraineurs vs. healthy controls. The current tools of migraine pain measurement are inadequate to distinguish the overall burden of suffering, as there is an over reliance on a single numerical pain score to represent the entire pain experience. Measuring and targeting the affective component, in addition to the sensory component of pain, may capture this discrepancy in disease burden. The affective component of migraine pain may be just as important as the sensory component to target and measure since it significantly impacts outcomes, disability, and has therapeutic treatment implications. Quantitative sensory testing (QST) is a robust lab paradigm (not a clinical experience) that delivers one painful noxious thermal stimuli and asks for simultaneous pain intensity and pain unpleasantness scores. By using this in the research, investigators will be able to differentiate the sensory (pain quality-what the pain feels like) from the affective (how awful/unpleasant the pain feels) components of experimental pain in normal controls vs. migrainuers. No previous studies have evaluated differences in experimental pain intensity vs. pain unpleasantness in migraineurs vs. controls. As migraine pain uniquely involves many altered sensory phenomenon (e.g., photophobia, phonophobia), it cannot be assumed that responses to experimental pain in migraine will be the same as other clinical pain syndromes. Further, different clinical pain syndromes have distinct responses to pain intensity vs. pain unpleasantness.

Interventions

  • OTHER Questionnaires
  • OTHER Quantitative Sensory Testing (QST) Pain Measurements

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2016-08-24
Est. Completion 2019-07-16
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT02748577

The ClinicalTrials.gov registry entry for NCT02748577 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.

NCT02748577 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02748577 about?

NCT02748577 is a clinical study titled "Pain Processing in Adults With Migraines". Primary Objective of this study: To assess experimental heat pain responses (pain intensity, pain unpleasantness, pain catastrophizing, emotional reactivity) in migraineurs vs. healthy controls. The current tools of migraine pain measurement are inadequate to distinguish the overall burden of suffe...

What is the current status of trial NCT02748577?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2016-08-24. Estimated completion is 2019-07-16.

What interventions are being tested in trial NCT02748577?

The interventions under investigation include: Questionnaires (OTHER), Quantitative Sensory Testing (QST) Pain Measurements (OTHER).

Who is sponsoring clinical trial NCT02748577?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.